H.R. 4200 · 110th Congress
To amend the Internal Revenue Code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products.
- Stage
- In committee
- Sponsor
- Ed Towns
- Introduced
- 2007-11-15
- Latest action
- 2007-11-15 · Introduced in House
Subjects
Health
Taxation
Commerce
Science, Technology, Communications
Income tax
Vaccines
Pharmaceutical research
Preventive medicine
Communicable diseases
Medical tests
Drug industry
Virus diseases
Antibiotics
Research and development tax credit